These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11439417)

  • 21. Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.
    Andrade C
    J Clin Psychiatry; 2012 Nov; 73(11):e1362-4. PubMed ID: 23218164
    [No Abstract]   [Full Text] [Related]  

  • 22. Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison.
    Dalery J; Honig A
    Hum Psychopharmacol; 2003 Jul; 18(5):379-84. PubMed ID: 12858325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggravation of glaucoma with fluvoxamine.
    Jiménez-Jiménez FJ; Ortí-Pareja M; Zurdo JM
    Ann Pharmacother; 2001 Dec; 35(12):1565-6. PubMed ID: 11793621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperphagia and self-mutilation in Prader-Willi syndrome: psychopharmacological issues.
    Yaryura-Tobias JA; Grunes MS; Bayles ME; Neziroglu F
    Eat Weight Disord; 1998 Dec; 3(4):163-7. PubMed ID: 10728166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
    Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
    Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine.
    Warnock JK; Clayton AH; Shaw HA; O'Donnell T
    Psychopharmacol Bull; 1995; 31(2):239-42. PubMed ID: 7491374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naltrexone and fluoxetine in Prader-Willi syndrome.
    Benjamin E; Buot-Smith T
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):870-3. PubMed ID: 8340312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ecchymoses as an adverse effect of fluvoxamine treatment in an adolescent girl.
    Vlatka BM; Branka AM; Branimir M
    Gen Hosp Psychiatry; 2010; 32(4):e9-e10. PubMed ID: 20633737
    [No Abstract]   [Full Text] [Related]  

  • 29. Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination.
    Pratheesh PJ; Praharaj SK; Srivastava A
    Psychopharmacol Bull; 2011; 44(1):70-3. PubMed ID: 22506441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood trichotillomania. Successful treatment with fluoxetine following an SSRI failure.
    Palmer CJ; Yates WR; Trotter L
    Psychosomatics; 1999; 40(6):526-8. PubMed ID: 10581985
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Mandrioli R; Mercolini L; Saracino MA; Raggi MA
    Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors.
    Kindler S; Dannon PN; Iancu I; Sasson Y; Zohar J
    Clin Neuropharmacol; 1997 Apr; 20(2):126-9. PubMed ID: 9099464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients].
    Montejo AI; Llorca G; Izquierdo JA; Ledesma A; Bousoño M; Calcedo A; Carrasco JL; Daniel E; de Dios A; de la Gándara J; Derecho J; Franco M; Gómez MJ; Macías JA; Martín T; Pérez V; Sánchez JM; Sánchez S; Vicens E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(6):311-21. PubMed ID: 9054202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluvoxamine for the treatment of anxiety disorders in children and adolescents.
    Isaacs E
    N Engl J Med; 2001 Aug; 345(6):466-7. PubMed ID: 11496864
    [No Abstract]   [Full Text] [Related]  

  • 36. Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors.
    Fux M; Taub M; Zohar J
    Acta Psychiatr Scand; 1993 Oct; 88(4):235-7. PubMed ID: 8256637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal Side Effects in the Baby of a Breastfeeding Woman Treated with Low-Dose Fluvoxamine.
    Uguz F
    J Hum Lact; 2015 Aug; 31(3):371-3. PubMed ID: 25896469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morbid obesity in an adolescent with Prader-Willi syndrome.
    Santos VM; Henrique de Paula F; Osterne EM; Nery NS; Turra TZ
    Rev Med Chil; 2009 Feb; 137(2):264-8. PubMed ID: 19543650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological treatment of paraphilias with a focus on antidepressants.
    Balon R
    J Sex Marital Ther; 1998; 24(4):241-54. PubMed ID: 9805285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicity with selective serotonin reuptake inhibitors.
    Solomons K; Gooch S; Wong A
    Am J Psychiatry; 2005 Jun; 162(6):1225. PubMed ID: 15930079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.